GI & Endoscopy

The FDA approved Sebela Pharmaceuticals' colonoscopy preparation tablet Sutab, the company announced Nov. 10. 

  Here are the five most-read stories about gastroenterology and endoscopy from Nov. 5-13:

Researchers developed a model that can predict an individual patient's risk to develop advanced precancerous polyps and colon cancer, Medical Xpress reported Nov. 10.

  Here are 10 updates from gastroenterology companies and practices in the last week:

Three physicians recently completed the first robotic-assisted colon resection surgeries at Martinsburg, W.Va.-based Berkeley Medical Center.

Docbot's artificial intelligence platform can be trained to predict levels of ulcerative colitis severity after reviewing full-length endoscopy videos, AiThority reported Nov. 6.

Ellen Scherl, MD, research director of the Jill Roberts Center for Inflammatory Bowel Disease at New York City-based Weill Cornell Medicine, spoke with NextServices President Praveen Suthrum about the future of the specialty.

Bellingham, Wash.-based Northwest Gastroenterology and Endoscopy recently broke ground on a 23,817-square-foot medical office building and endoscopy center, Whatcom Talk reported Nov. 6.

Alison Schneider, MD, was elected president of the Florida Gastroenterologic Society at the organization's 55th annual meeting, South Florida Hospital News reported Nov. 6.

  San Diego-based Prometheus Biosciences completed a $130 million equity financing led by Eventide Asset Management and RTW Investments for the development of inflammatory bowel disease treatment, according to a Nov. 9 press release.